Gentler breathing support may help preemies avoid harsh ventilators
NCT ID NCT07307079
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 100 premature babies (26-36 weeks) with respiratory distress syndrome who didn't improve with standard nasal CPAP. Researchers compared a newer, non-invasive high-frequency ventilation method (nHFOV) with traditional mechanical ventilation. The goal was to see which method improved oxygen levels better and led to fewer complications like lung damage or infections.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Non-Invasive High-Frequency Oscillatory Ventilation (nHFOV) and Conventional Mechanical Ventilation (CMV)
- What this could lead to
- If nHFOV works better, it could offer a gentler breathing support option for premature babies, potentially reducing lung injury and other complications.
- What could go wrong
- This is a small, completed study. Results may not apply to all hospitals or babies. Both methods have risks like infection or air leaks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY DISTRESS SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Indus Hospital - Recep Tayyip Erdogan Campus, Muzaffargarh
Muzaffargarh, Punjab Province, 32400, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can gentle oscillations help premature babies breathe better?
- Could a tiny tube spare preterm babies from breathing machines?
- Can an Oxygen-Boosting drug help when all else fails?
- Can a steroid shot into the windpipe protect preemies' lungs?
- Experimental 'Storm Stopper' therapy tested for COVID-19, flu, and RSV
- Simple bedside ultrasound may spot lung risk in preemies